BioLine RX Ltd ADR buy BiotechBee
Start price
03.09.23
/
50%
€1.97
Target price
31.07.25
€2.50
Performance (%)
18.78%
End price
06.09.23
€2.34
Summary
This prediction ended on 06.09.23 with a price of €2.34. The BUY prediction by BiotechBee finished with a performance of 18.78%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioLine RX Ltd ADR | - | - | - |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % |
According to BiotechBee what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread BioLine RX Ltd ADR diskutieren
Buy mit Kursziel 2,5

